CervoMed Inc. Shareholders' Equity
CervoMed Inc. (CRVO) had Shareholders' Equity of $22.96 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity Attributable to Parent $22.96M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $10.62M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $18.22M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $26.01M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $22.96M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $10.62M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $18.22M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $26.01M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $33.44M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $34.63M 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $39.20M 10-Q · filed 2026-08-07 | |
| 2024-09-30 | $45.64M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $49.98M 10-Q · filed 2025-08-08 | |
| 2024-03-31 | $5.34M 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $7.38M 10-K · filed 2026-03-13 | |
| 2023-09-30 | $9.57M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$35.11M 10-Q · filed 2024-11-12 | $14.23M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$33.75M 10-Q · filed 2024-08-09 | $16.28M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$33.29M 10-K · filed 2025-03-17 | $20.22M 10-K · filed 2023-03-24 |
| 2022-09-30 | $24.05M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $26.67M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $30.62M 10-Q · filed 2022-08-12 | |
| 2021-12-31 | $34.91M 10-K · filed 2023-03-24 | |
| 2021-09-30 | $38.13M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $50.17M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $53.65M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $24.81M 10-Q · filed 2022-05-12 | |
| 2020-09-30 | $28.72M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $32.88M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $17.90M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $20.13M 10-K · filed 2021-03-17 | |
| 2019-09-30 | $13.52M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $16.18M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $12.95M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $15.61M 10-K · filed 2020-03-17 | |
| 2018-09-30 | $20.91M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $27.30M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $29.72M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $21.23M 10-K · filed 2019-03-19 | |
| 2017-09-30 | $6.36M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $1.17M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$19.12M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $9.18M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $11.49M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $14.03M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $16.58M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$41.62K 10-K · filed 2017-03-31 | |
| 2014-12-31 | $38.17M 10-K · filed 2015-04-03 | |
| 2014-09-30 | $42.80M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $45.30M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $12.22M 10-Q · filed 2014-05-20 | |
| 2013-12-31 | $6.46M 10-K · filed 2015-04-03 | |
| 2013-09-30 | -$6.29M 10-Q · filed 2013-11-19 | |
| 2013-06-30 | -$8.54M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$19.71M 10-Q/A · filed 2013-05-20 | |
| 2012-12-31 | -$18.39M 10-K/A · filed 2014-04-23 | |
| 2012-09-30 | -$6.03M 10-Q · filed 2012-11-19 | |
| 2012-06-30 | -$5.07M 10-Q/A · filed 2012-09-07 | |
| 2011-12-31 | -$16.06M 10-K/A · filed 2014-04-23 | -$143.43K 10-Q/A · filed 2012-09-07 |
| 2011-09-30 | $5.05M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $8.65M 10-Q · filed 2011-08-16 | |
| 2010-12-31 | $20.22K 10-Q · filed 2011-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |